Nuclear Medicine & Radiation Therapy

ISSN: 2155-9619

Open Access

Thomas J. Dilling

Moffitt Cancer Center  


 Dr. Dilling's primary clinical focus is the radiotherapeutic treatment of thoracic malignancies. He is interested in the application of new technologies to the treatment of lung cancer, with the ongoing goal to improve treatment efficacy while minimizing untoward side effects. In particular, Dr. Dilling is interested in the use of stereotactic radiotherapy for the treatment of early-stage lung cancers, and is also interested in tumoral genetic mutations which might confer greater (or reduced) radiation sensitivity

Research Interest

 lung cancer

Relevant Topics

Google Scholar citation report
Citations: 706

Nuclear Medicine & Radiation Therapy received 706 citations as per Google Scholar report

Nuclear Medicine & Radiation Therapy peer review process verified at publons

Indexed In

arrow_upward arrow_upward